Summary
Annexon Biosciences
Founded in 2011
Description
Annexon Biosciences is a California-based healthcare company engaged in the research and development of novel disease modifying drugs for neurodegenerative disorders. They are focused on developing a new class of complement medicines for patients with ...
Strengths
- Annexon Biosciences has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Annexon Biosciences was founded, the company has grown faster than the industry average
Weaknesses
- Variance of revenue growth is more than the industry average
- Web traffic rankings are worse than the industry average
Annual Revenue
Annexon Biosciences's annual revenue
$20592000
Based on Kona Equity data
-
Revenue per employee
$326857
-
Variance of revenue growth
0.63
-
Annual revenue growth since founding
$1584000
-
Revenue growth rate from first known quarter to current
197.9%
Employee Count
63 employees
-
Employee growth rate from first known quarter to current
76.5%
Executives
Melissa Shaw
Intellectual Property Vice President, Legal
m**@annexonbio.comJennifer Lew
Executive VP & Chief Financial Officer
j**@annexonbio.comMarta Schumacher
Global Senior Director, Clinical Operations
m**@annexonbio.comDouglas Love
CEO
d**@annexonbio.comChenying Guo
Director, Research
c**@annexonbio.comPaul Manser
Director of Biostatistics
p**@annexonbio.comCecilia Oliyai
Vice President, CMC & Supply Chain Logistics
c**@annexonbio.comChristina Huynh
Ra Ii
c**@annexonbio.comNathan Weedin
Global Medical Affairs-Autoimmune Head
n**@annexonbio.comSaniya Hussain
Manager, Clinical Trial
s**@annexonbio.comQing Chang
Vice President, Global Team Leader, Portfolio Strategy and Management
q**@annexonbio.comAj Acker
Senior VP, Regulatory & Quality Assurance
a**@annexonbio.comAnnalisa Mclafferty
Senior CTM
a**@annexonbio.comLarry Mattheakis
Executive VP & Chief Scientific Officer
l**@annexonbio.comSaba Aleem
Vice President, Finance
s**@annexonbio.comAdrian Johnson
Director, Global Pharmacovigilance
a**@annexonbio.comKris Fortner
Vice President, Corporate Communications
k**@annexonbio.comLori Taylor
Senior VP, Portfolio Strategy & Operations
l**@annexonbio.comAdrian Chew
Vice President, Project Team Leader
a**@annexonbio.comEric Humphriss
Global Vice President, Clinical Operations
e**@annexonbio.comAlessia Tassoni
Scientist
a**@annexonbio.comCharles Bradley
Global Senior VP, Development Operations
c**@annexonbio.comMichael Overdorf
Executive VP & Chief Business Officer
m**@annexonbio.comVlad Volman
Associate Director of Translational Bioinformatics
v**@annexonbio.comPhone Biosciences
President & Chief Executive Officer
p**@annexonbio.comG Score - 5
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Web Analysis
-
Rank
6.26 M
-
Page views per visitor
2.0
-
Daily time
-
Location
Unlock unlimited leads
Similar Companies
Atea Pharmaceuticals
ateapharma.com- Founded in 2012
- Location: Boston, MA
- Annual Revenue: $285.4M
- Employees: 64
- Atea Pharmaceuticals is a leader in the discovery of oral direct acting antiviral therapies, including our most advanced drug candidate, bemnifosbuvir (AT 527). Originating from our nucleos(t)ide discovery capabilities, bemnifosbuvir (AT 527) is an ora...
Checkmate Pharmaceuticals Inc.
checkmatepharma.com- Founded in 2015
- Location: Cambridge, MA
- Annual Revenue: $10.1M
- Employees: 30
- Empowering the immune system to beat back cancer
Leap Therapeutics
leaptx.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $1.1M
- Employees: 36
- Leap Therapeutics, Inc. (Nasdaq: LPTX) is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer patients. Their most advanced clinical candidate, DKN 01, is a humanized monoclonal antibody...
Axsome Therapeutics
axsome.com- Founded in 2012
- Location: New York City, NY
- Annual Revenue: $50.0M
- Employees: 383
Galera Therapeutics, Inc.
galeratx.com- Founded in 2009
- Location: Malvern, PA
- Annual Revenue: $6.3M
- Employees: 30
- This is the home page.
GlycoMimetics
glycomimetics.com- Founded in 2003
- Location: Rockville, MD
- Annual Revenue: $104.0K
- Employees: 52
- GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. GlycoMimetics is a late clinical stage biotechnology company discovering and developing glycobiology based therapies for cancers...
Key Information
- Name: Annexon Biosciences
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 80; 283
- NAICS: 541; 5417
See similar companies
-
By City South San Francisco Small Biotechnology Company in South San Francisco Mid-size Biotechnology Company in South San Francisco Pharmaceuticals in South San Francisco Small Pharmaceuticals in South San Francisco Mid-size Pharmaceuticals in South San Francisco
-
By State CA Small companies in CA Pharmaceuticals in CA Small Pharmaceuticals in CA Mid-size Pharmaceuticals in CA Small Biotechnology Company in CA Mid-size Biotechnology Company in CA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 5 Founded in 2011 SIC: 80 SIC: 283 NAICS: 541 NAICS: 5417 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Annexon Biosciences's headquarters are located at 180 Kimball Way 2nd Fl. Ste. 200 South San Francisco, CA 94080.
Annexon Biosciences's official website is annexonbio.com
Annexon Biosciences's annual revenue is $20.6 M.
Annexon Biosciences's SIC: 80; 283
Annexon Biosciences's NAICS: 541; 5417.
Annexon Biosciences has 63 employees
Annexon Biosciences is in the industry of Pharmaceuticals.
